Efficacy and Safety of Pyronaridine-Artesunate Versus Artemether-Lumefantrine

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

172

Participants

Timeline

Start Date

May 20, 2019

Primary Completion Date

December 23, 2020

Study Completion Date

December 23, 2020

Conditions
Malaria FeverPlasmodium Falciparum MalariaUncomplicated Malaria
Interventions
DRUG

Antimalarials, pyronaridine-artesunate

The main interventions investigated are pyronaridine-artesunate granules or tablets (Pyramax™) manufactured by Shin Poong Pharmaceuticals, Seoul, Korea. Pyramax granules come in sachets with each containing 60mg of pyronaridine/20mg of artesunate while Pyramax tablets contain 180mg pyronaridine/60mg artesunate.

DRUG

Antimalarials, Artemether + Lumefantrine

Artemether-lumefantrine dispersible tablets (Coartem™, Novartis pharma) twice daily according to body weights. Each dispersible tablet of AL contains 20mg of artemether/120mg of lumefantrine).

Trial Locations (1)

200212

Ikeoluwapo O Ajayi, Ibadan

All Listed Sponsors
collaborator

Shin Poong Pharm Co Ltd 161 yoksam-ro, Gangnam-Gu Seoul 135-925, Korea

UNKNOWN

collaborator

Institute for Advanced Medical Research and Training, University of Ibadan, Ibadan

UNKNOWN

lead

University of Ibadan

OTHER

NCT05192265 - Efficacy and Safety of Pyronaridine-Artesunate Versus Artemether-Lumefantrine | Biotech Hunter | Biotech Hunter